DE602004021724D1 - Verfahren zum nachweis des felinen immunschwächevirus - Google Patents

Verfahren zum nachweis des felinen immunschwächevirus

Info

Publication number
DE602004021724D1
DE602004021724D1 DE602004021724T DE602004021724T DE602004021724D1 DE 602004021724 D1 DE602004021724 D1 DE 602004021724D1 DE 602004021724 T DE602004021724 T DE 602004021724T DE 602004021724 T DE602004021724 T DE 602004021724T DE 602004021724 D1 DE602004021724 D1 DE 602004021724D1
Authority
DE
Germany
Prior art keywords
fiv
detecting
animal
polypeptides
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004021724T
Other languages
English (en)
Inventor
Groat G Randall
Tonelli J Quentin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Idexx Laboratories Inc
Original Assignee
Idexx Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idexx Laboratories Inc filed Critical Idexx Laboratories Inc
Publication of DE602004021724D1 publication Critical patent/DE602004021724D1/de
Anticipated expiration legal-status Critical
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE602004021724T 2003-12-18 2004-12-17 Verfahren zum nachweis des felinen immunschwächevirus Active DE602004021724D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53056403P 2003-12-18 2003-12-18
US58469404P 2004-06-30 2004-06-30
PCT/US2004/042446 WO2005062053A2 (en) 2003-12-18 2004-12-17 Method and device for detecting feline immunodeficiency virus

Publications (1)

Publication Number Publication Date
DE602004021724D1 true DE602004021724D1 (de) 2009-08-06

Family

ID=34713775

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004021724T Active DE602004021724D1 (de) 2003-12-18 2004-12-17 Verfahren zum nachweis des felinen immunschwächevirus

Country Status (8)

Country Link
US (1) US7285272B2 (de)
EP (1) EP1709447B1 (de)
JP (1) JP4717009B2 (de)
AT (1) ATE434763T1 (de)
AU (1) AU2004304348B2 (de)
CA (1) CA2550264C (de)
DE (1) DE602004021724D1 (de)
WO (1) WO2005062053A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007523170A (ja) * 2004-02-19 2007-08-16 アイデックス ラボラトリーズ インコーポレイテッド ネコ免疫不全ウイルスの検出のための方法および装置
JP4772111B2 (ja) 2006-03-06 2011-09-14 シャープ株式会社 通知情報生成装置、通信装置、通知情報生成方法およびプログラム
CA2693305A1 (en) * 2007-07-25 2009-01-29 The Kitasato Institute Test method on feline vaccinated with feline immunodeficiency virus vaccine, and antigen for use in the test

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4629783A (en) 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
US4879212A (en) 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
CA1341439C (en) 1987-08-26 2003-09-23 Niels C. Pedersen Feline t-lymphotropic lentivirus
US5118602A (en) 1987-08-26 1992-06-02 The Regents Of The University Of California Feline T-lymphotropic lentivirus assay
US4900548A (en) 1987-11-13 1990-02-13 Harvard University Use of diethylcarbamazine to enhance antigen-antibody and antigen-host immune cell interactions
JPH0211524A (ja) * 1988-06-29 1990-01-16 Gen Corp:Kk オーエスキー病ワクチンの製造方法及び該ワクチン接種豚と自然感染豚との識別方法
CA1335880C (en) 1988-07-14 1995-06-13 Thomas P. O'connor Detection of an antibody and antigen in an immunoassay
US5177014A (en) 1988-12-05 1993-01-05 Idexx Laboratories, Inc. Monoclonal antibodies to feline-T-lymphotropic lentivirus
US5219725A (en) 1988-12-05 1993-06-15 Idexx Laboratories Incorporated Monoclonal antibodies to feline-t-lymphotropic lentivirus
WO1990013573A1 (en) 1989-05-08 1990-11-15 Idexx Corporation Polypeptides of feline t-cell lymphotropic lentivirus
FR2669338A1 (fr) 1990-11-21 1992-05-22 Centre Nat Rech Scient Fragments peptidiques issus de la proteine externe du vif, anticorps antifragments, application de ceux-ci au diagnostic et/ou au traitement de l'immunodeficience feline.
US6228608B1 (en) 1991-02-28 2001-05-08 Aquila Biopharmaceuticals, Inc. Recombinant FIV glycoprotein 160 and P24 gag protein
CA2111325C (en) 1991-06-14 2007-10-23 Bruce Ernest Kemp Detection of mammalian immunodeficiency viruses
WO1993001304A1 (en) 1991-07-10 1993-01-21 Synbiotics Corporation Synthetic peptides related to fiv-env proteins
US5726010A (en) 1991-07-31 1998-03-10 Idexx Laboratories, Inc. Reversible flow chromatographic binding assay
US5736378A (en) 1991-09-12 1998-04-07 The Scripps Research Institute Molecular cloning and characterization of the feline immunodeficiency virus isolate PPR
GB9215232D0 (en) 1992-07-17 1992-09-02 Pitman Moore Inc Vaccines
GB9219936D0 (en) 1992-09-21 1992-11-04 Pitman Moore Inc Vaccines
US5462852A (en) 1992-10-28 1995-10-31 The Government Of The United States Of America, As Represented By The Secretary, Dhhs HIV Nucleocapsid protein capture assay and method of use
DE4242475A1 (de) 1992-12-16 1994-06-23 Suspa Compart Ag Führungsbuchse, insbesondere für längenverstellbare Stuhl-Säule und Stuhl-Säule mit derartiger Führungsbuchse
JPH07159408A (ja) * 1993-12-09 1995-06-23 Biseibutsu Kagaku Kenkyusho:Kk オーエスキー病ウイルス感染抗体識別用抗原
US5576177A (en) 1994-03-09 1996-11-19 St. Jude Children's Research Hospital Bioassay for reverse transcriptase inhibitors
ATE334216T1 (de) 1994-04-29 2006-08-15 Pharmacia & Upjohn Co Llc Impstoff gegen felines immunodefizienz-virus
FR2721031B1 (fr) 1994-06-09 1996-07-26 Centre Nat Rech Scient Fragment peptidique spécifique du virus de l'immunodéficience féline (VIF) et son utilisation comme réactif de diagnostic.
WO1996003652A1 (de) 1994-07-25 1996-02-08 Boehringer Mannheim Gmbh Bestimmung von spezifischem immunglobulin unter verwendung multipler antigene
FR2732346B1 (fr) 1995-03-27 1997-05-30 Centre Nat Rech Scient Proteines mutees, codees par un gene env mute de lentivirus, fragments peptidiques inclus dans lesdites proteines, vecteurs d'expression exprimant lesdites proteines mutees et leurs applications
US5820869A (en) 1995-06-07 1998-10-13 American Home Products Corporation Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
US5849303A (en) 1995-06-07 1998-12-15 American Home Products Corporation Recombinant feline Immunodeficiency virus subunit vaccines employing baculoviral-expressed envelope glycoproteins derived from isolate NCSU-1 and their use against feline immunodeficiency virus infection
US6300118B1 (en) 1995-06-07 2001-10-09 American Home Products Corporation Plasmids comprising a genetically altered feline immunodeficiency virus genome
AU728750B2 (en) 1995-08-25 2001-01-18 Regents Of The University Of California, The Multi-subtype FIV vaccines
US6254872B1 (en) 1995-08-25 2001-07-03 University Of Florida Multi-subtype FIV vaccines
US6077662A (en) 1996-11-27 2000-06-20 Emory University Virus-like particles, methods and immunogenic compositions
US6331616B1 (en) 1997-03-05 2001-12-18 North Carolina State University Nucleic acids obtained from the envelope coding region of feline immunodeficiency virus molecular clone designated JSY3
EP0887412B1 (de) * 1997-05-26 2003-10-15 Akzo Nobel N.V. Rekombinanter Birnavirusimpfstoff
FR2769916B1 (fr) 1997-10-17 2000-12-01 Centre Nat Rech Scient Peptides issus du gene env du virus de l'immunodeficience feline et leurs applications immunoprotectrices et vaccinales
FR2771011B1 (fr) 1997-11-17 2000-01-28 Hippocampe Obtention de vaccins destines a prevenir les effets pathogenes associes a une infection retrovirale
DE69837105D1 (de) 1997-12-05 2007-03-29 Univ New Mexico Verfahren zur reinigung von hitze-schock peptidkomplexen
US6284253B1 (en) 1998-01-29 2001-09-04 Cornell Research Foundation, Inc. Feline immunodeficiency virus (FIV) nucleotide sequence
US6458528B1 (en) 1998-05-15 2002-10-01 Idexx Laboratories, Inc. Diagnosis of feline immunodeficiency virus infection using ENV/GAG polypeptide markers
AU6683400A (en) 1999-07-08 2001-01-30 Mologen Forschungs-, Entwicklungs- Und Vertriebs Gmbh Vaccine against lentiviral infections, such as the feline immune deficiency virus of the cat
US6420591B1 (en) 1999-10-04 2002-07-16 University Of Medicine And Dentistry Of New Jersey Carbamates and compositions thereof, and methods for their use for treating cancer, inflammation, or a viral infection
FR2828687B1 (fr) 2001-08-17 2003-12-12 Hippocampe Nouveaux peptides et leur utilisation comme medicaments contre l'infection par le fiv chez le chat
AU2004238367A1 (en) 2003-05-12 2004-11-25 University Of Florida Research Foundation, Inc. Materials and methods for immunizing against FIV infection
ATE435425T1 (de) * 2003-09-11 2009-07-15 Idexx Lab Inc Verfahren zum nachweis des felinen immunschwächevirus

Also Published As

Publication number Publication date
ATE434763T1 (de) 2009-07-15
AU2004304348B2 (en) 2009-02-26
US20050136401A1 (en) 2005-06-23
JP4717009B2 (ja) 2011-07-06
US7285272B2 (en) 2007-10-23
AU2004304348A1 (en) 2005-07-07
EP1709447B1 (de) 2009-06-24
CA2550264A1 (en) 2005-07-07
CA2550264C (en) 2011-06-28
JP2007514753A (ja) 2007-06-07
WO2005062053A3 (en) 2005-09-29
WO2005062053A2 (en) 2005-07-07
EP1709447A2 (de) 2006-10-11

Similar Documents

Publication Publication Date Title
ATE385259T1 (de) Verfahren zum nachweis von influenza a/b-viren in speichel
Mortimer et al. Detection of antibody to HIV in saliva: a brief review
HUP0303134A2 (hu) HIV-peptidek, antigének, vakcinakészítmények, immunológiai mérési reagenskészletek és eljárás HIV által indukált antitestek detektálására
ATE317242T1 (de) Vorrichtung zum sammeln von flüssigen proben
HK1108468A1 (en) Optoelectronic detection system
ATE403153T1 (de) Test zum direkten nachweisen einer rs virus bezogenen biologischen zelle in einer körperflüssigkeitsprobe
ES2139571T3 (es) Ensayo de hepatitis c que utiliza antigenos recombinantes.
DE602006021162D1 (de) Verfahren und vorrichtung zum nachweis von katzen-immunschwächevirus
DE602005009819D1 (de) Verfahren zum nachweis von infektionen mit mykobakterien
WO2007008092A3 (en) Diagnostic kit for the examination of animal sera for the presence of anti-rhd antibodies and a diagnostic kit for detecting the rhd virus
DE602004021724D1 (de) Verfahren zum nachweis des felinen immunschwächevirus
DE602005027326D1 (de) Verfahren und vorrichtung zum nachweis von katzen-immunschwächevirus
ATE516502T1 (de) Nachweis des westnil-virus
EA200700345A1 (ru) Обогащённое антитело для выявления микобактериальной инфекции, способы применения и диагностические тесты, применяющие такое антитело
JP2005538343A5 (de)
HK1091540A1 (en) Use of a virus expressing a binding moiety to measure analytes in a sample
WO2005024427A3 (en) Detection of west nile virus infection and vaccination
DE602004021829D1 (de) Verfahren zum nachweis des felinen immunschwächevirus
DE60131962D1 (de) Verfahren und zusammensetzungen zum nachweis von taenia solium larven mittels eines klonierten antigens
ATE504662T1 (de) Nachweis des bovinen virusdiarrhoe-virus in gewebeproben
ATE391914T1 (de) Assay
CA2576930A1 (en) Method and device for detecting feline immunodeficiency virus (fiv) comprising the use of peptides derived from the v3 region of the fiv env protein
Metcalf et al. The prevalence of antibodies against Borrelia burgdorferi found in horses residing in the Northwestern United States
WO2006088739A8 (en) Assays for detecting the tat protein in hiv-1 infection
RU2020139003A (ru) Способ и средство для быстрого обнаружения инфекций вируса гепатита d

Legal Events

Date Code Title Description
8364 No opposition during term of opposition